Delivery Order SPE2DR25D3103-SPE2DR26F9V91
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,822.46 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Vemlidy 25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract has a ceiling value of $7,019.30 and was executed on December 22, 2025, with an ultimate completion date of December 23, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken facility, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $6,832.55 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count unit) on October 27, 2025, with completion scheduled for October 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,980.71 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on November 3, 2025, with completion targeted for November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.33 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-tablet units) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,770.92 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit of use packaging). The contract was competitively awarded without set-aside provisions and is classified as a firm fixed price delivery order, with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a $12,507.84 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of January 5, 2026, and represents a child order under a larger contract vehicle. The award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, valued at $4,584.29. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, issued under a competitive procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,823.97 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in a quantity of 30 units. The contract, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a $8,731.21 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on October 24, 2025, with completion expected by October 27, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement typical of pharmaceutical supply transactions under the DLA's medical procurement framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9V91Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,932.38 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 9, 2026, with completion scheduled for January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle. The IDC enables the contractor to deliver a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The contract demonstrates the contractor's established capability to efficiently fulfill government pharmaceutical requirements for military treatment facilities and federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 1/8/26 |